Nasdaq

NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery

SAN DIEGO, Sept. 9, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
Nasdaq

NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine

Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc's superiority to ACDF The peer-reviewed publication reiterates that the Simplify Disc ...
Yahoo Finance

Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Yahoo Finance

FDA Approves NuVasive’s Simplify Disc For Two-Level Cervical Total Disc Replacement

NuVasive announced that the US Food and Drug Administration (FDA) has approved the NuVasive Simplify Cervical Artificial Disc (Simplify Disc) for two-level cervical total disc replacement (cTDR).
Yahoo Finance

NuVasive (NUVA) Boosts Cervical Portfolio With New Buyout

NuVasive, Inc. NUVA recently announced the acquisition of Simplify Medical to strengthen its cervical portfolio and provide a complete solution for cervical total disc replacement procedures. NuVasive ...
Business Insider

Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK

SAN DIEGO, April 22, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
Mena FN

NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine'

Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc's superiority to ACDF SAN DIEGO, April 21, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: ...